Publicaciones en colaboración con investigadores/as de New York University Langone Medical Center (67)

2024

  1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  2. IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management—an International Delphi Study

    Obesity Surgery, Vol. 34, Núm. 1, pp. 30-42

  3. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

    European Urology

  4. Metabolic and Bariatric Surgery in Patients with Obesity Class V (BMI > 60 kg/m2): a Modified Delphi Study

    Obesity Surgery, Vol. 34, Núm. 3, pp. 790-813

2023

  1. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

    New England Journal of Medicine, Vol. 389, Núm. 22, pp. 2039-2051

  2. Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

    Annals of Oncology, Vol. 34, Núm. 3, pp. 289-299

2022

  1. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Circulation, Vol. 146, Núm. 16, pp. 1196-1206

  2. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1852-1862

  3. Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362))

    European journal of human genetics : EJHG

  4. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

    European journal of human genetics : EJHG, Vol. 30, Núm. 3, pp. 349-362

  5. Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials

    Clinical Cancer Research, Vol. 28, Núm. 10, pp. 2050-2060

  6. Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

    Molecular Neurodegeneration, Vol. 17, Núm. 1

2021

  1. Autophagy in major human diseases

    EMBO Journal, Vol. 40, Núm. 19

  2. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells

    Nature Aging, Vol. 1, Núm. 9, pp. 850-863

  3. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 78, Núm. 8, pp. 840-853

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  5. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  6. Management in the ICU

    ERS Monograph, Vol. 2021, Núm. 94, pp. 124-143

  7. Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial

    Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027

  8. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: An international cohort study

    BMJ Open, Vol. 11, Núm. 11